Cancer Community Resources | FDA - U.S. Food and Drug Administration
We have gathered information below on several topics from the FDA, the U.S. National Cancer Institute, and the U.S. Centers for Disease Control and Prevention.
Oncology (Cancer)/Hematologic Malignancies Approval …
On December 4, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) for adults with limited-stage small cell lung cancer (LS-SCLC) whose disease …
Oncology Center of Excellence - U.S. Food and Drug Administration
OUR VISION: We seek to create a unified and collaborative scientific environment to advance the development and regulation of oncology products for patients with cancer.
FDA initiative for diversity in cancer studies disappears : Shots
4 days ago · A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts …
Darzalex Faspro, Sarclisa Approvals for Multiple Myeloma
Jan 7, 2025 · Two recent approvals by the Food and Drug Administration (FDA) broaden the initial treatment options for people who have a new diagnosis of multiple myeloma. On July 30, FDA …
US bans red dye No. 3 from food, candy and medicine - BBC
Jan 16, 2025 · Manufacturers will no longer be allowed to use the dye, called red No 3 or red dye 3, after studies linked it to cancer in male laboratory rats, the US Food and Drug …
An Overview of Cancer Drugs Approved by the US Food and Drug ...
The US Food and Drug Administration (FDA) approves cancer drugs based on (1) overall survival (OS) or patient reported outcomes, (2) progression-free survival, ie, the time until cancer …
The FDA pulls key DEI initiative for cancer studies from its website
4 days ago · A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts …
Cancer Immunotherapy Update: FDA-Approved Checkpoint …
Mar 7, 2021 · This review provides an update on ICIs approved by the Food and Drug Administration (FDA), with focus on monoclonal antibodies that target the programmed cell …
Clinical Trial Evidence Supporting US Food and Drug Administration ...
This comparative effectiveness research examines clinical trial data on treatment outcomes used to support US Food and Drug Administration approval of novel cancer therapies that were …
- Some results have been removed